PT KALBE FARMA TBK. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,490 IDR | 0.00% |
|
+6.05% | -7.45% |
| 30/04 | PT Kalbe Farma Tbk. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 01/04 | PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar PT Kalbe Farma Tbk.
30.4eBoRCP5MTdvwgN44Fu9b7GnNQp7p0FgJS5pghape54.vqgxLFWIX1AZgzYXuQTqDdbTWFJDihlSEVQe6nTHGObZrywtTpNnRwGISg~4737b3c3e83f78d37c8870b8f2780212
Upcoming events on PT Kalbe Farma Tbk.
Past events on PT Kalbe Farma Tbk.
| 25/04/2024 | Q1 2024 Earnings Release (Projected) |
| 31/10/2023 10:04 am | Q3 2023 Earnings Release |
| 07/08/2023 12:20 pm | Q2 2023 Earnings Release |
| 12/05/2023 | Ex-dividend day for final dividend |
| 03/05/2023 08:30 am | Annual General Meeting |
| 28/04/2023 03:27 pm | Q1 2023 Earnings Release |
| 11/04/2023 04:45 pm | Q4 2022 Earnings Release |
| 31/10/2022 | Q3 2022 Earnings Release |
| 29/07/2022 | Interim 2022 Earnings Release |
| 31/05/2022 | Ex-dividend day for final dividend |
| 19/05/2022 08:30 am | Annual General Meeting |
| 28/04/2022 | Q1 2022 Earnings Release |
| 31/03/2022 | FY 2021 Earnings Release |
| 09/03/2022 06:00 am | ASEAN Consumer & Lifestyle Access |
| 25/10/2021 | Q3 2021 Earnings Release |
| 30/07/2021 | Interim 2021 Earnings Release |
| 27/05/2021 08:30 am | Annual General Meeting |
| 31/03/2021 | FY 2020 Earnings Release |
| 04/12/2020 | Ex-dividend day for dividende intermédiaire |
| 30/10/2020 | Q3 2020 Earnings Call |
Past dividends on PT Kalbe Farma Tbk.
| 12/05/2023 | Annual 38 IDR |
| 31/05/2022 | Annual 35 IDR |
| 08/06/2021 | Final Payment 28 IDR |
| 04/12/2020 | Interim Payment 6 IDR |
| 02/06/2020 | Annual 20 IDR |
| 10/06/2019 | Annual 26 IDR |
| 22/06/2018 | Annual 25 IDR |
| 13/06/2017 | Annual 22 IDR |
| 08/06/2016 | Annual 19 IDR |
| 26/05/2015 | Annual 19 IDR |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Billions IDR | Released Forecast Spread | 22 636 22 839 -0.89% | 23 113 23 585 -2% | 26 255 25 516 2.9% | 28 934 29 150 -0.74% | 30 449 30 922 -1.53% | 32 450 |
|
EBITDA Billions IDR | Released Forecast Spread | 3 771 4 017 -6.13% | 4 137 3 992 3.62% | 4 649 4 494 3.46% | 4 946 5 024 -1.55% | 4 360 4 496 -3.01% | 4 802 |
|
EBIT Billions IDR | Released Forecast Spread | 3 300 3 504 -5.82% | 3 555 3 442 3.3% | 4 021 3 880 3.64% | 4 231 4 368 -3.15% | 3 694 3 743 -1.31% | 4 079 |
|
Earnings before Tax (EBT) Billions IDR | Released Forecast Spread | 3 348 3 566 -6.11% | 3 628 3 543 2.38% | 4 073 3 977 2.41% | 4 459 4 542 -1.82% | 3 606 3 706 -2.68% | 3 990 |
|
Net income Billions IDR | Released Forecast Spread | 2 499 2 665 -6.23% | 2 733 2 683 1.87% | 3 074 3 047 0.9% | 3 382 3 488 -3.04% | 2 767 2 828 -2.18% | 3 067 |
|
EPS IDR | Released Forecast Spread | 53,5 56,8 -5.83% | 58,3 57,1 2.15% | 65,6 64,9 1.12% | 72,7 74,2 -2.02% | 59,8 60,9 -1.83% | 67,5 |
| Announcement Date | 27/02/20 | 07/04/21 | 22/02/22 | 28/03/23 | 01/04/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Billions IDR | Released Forecast Spread | 7 310 8 027 -8.94% | 7 888 7 960 -0.9% | |||||
|
EBITDA Billions IDR | Released Forecast Spread | 1 051 1 328 -20.89% | ||||||
|
EBIT Billions IDR | Released Forecast Spread | 878 1 155 -24.02% | 979 794 23.3% | |||||
|
Earnings before Tax (EBT) Billions IDR | Released Forecast Spread | 843 1 146 -26.4% | 955 771 23.89% | |||||
|
Net income Billions IDR | Released Forecast Spread | 802 904 -11.24% | 849 905 -6.2% | 897 884 1.44% | 856 935 -8.45% | 673 902 -25.36% | 536 854 -37.23% | 702 656 7.04% |
|
EPS IDR | Released Forecast Spread | 17,3 19,3 -10.47% | 18,3 19,3 -5.08% | 19,3 18,9 2.24% | 18,4 19,9 -7.73% | 14,5 20,9 -30.87% | 11,5 18,2 -36.76% | 15,4 14,9 3.35% |
| Announcement Date | 29/07/22 | 31/10/22 | 28/03/23 | 28/04/23 | 07/08/23 | 31/10/23 | 01/04/24 |
| 07/05/2024 | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED: Q4 2024 Earnings Release (Projected) |
| 07/05/2024 | EVOLUS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | DR. REDDY'S LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 07/05/2024 | PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | BLAU FARMACÊUTICA S.A.: Q1 2024 Earnings Release |
| 07/05/2024 04:00 pm | PERRIGO COMPANY PLC: Q1 2024 Earnings Release |
| 08/05/2024 01:30 am | OCULAR THERAPEUTIX, INC.: Q1 2024 Earnings Release |
| 08/05/2024 01:31 am | LIGAND PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release |
| 08/05/2024 01:35 am | SIGA TECHNOLOGIES, INC.: Q1 2024 Earnings Release |
| 08/05/2024 | IMMUNOCORE HOLDINGS PLC: Q1 2024 Earnings Release (Projected) |
Past sector events for PT Kalbe Farma Tbk.
| Today | GEN ILAC VE SAGLIK URUNLERI SANAYI VE TICARET ANONIM SIRKETI: Q1 2024 Earnings Release (Projected) |
| Today | PLIANT THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| Today | LUPIN LIMITED: Q4 2024 Earnings Release |
| Today | DRI HEALTHCARE TRUST: Q1 2024 Earnings Release |
| 03/05/2024 04:37 pm | AARTI DRUGS LIMITED: Q4 2024 Earnings Release |
| 03/05/2024 03:30 pm | AMNEAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
| 03/05/2024 | DEVA HOLDING: Q1 2024 Earnings Release (Projected) |
| 03/05/2024 01:31 am | AMGEN INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:13 pm | ALK-ABELLÓ A/S: Q1 2024 Earnings Release |
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- KLBF Stock
- Calendar PT Kalbe Farma Tbk.